CNSX:GTIIPharmaceuticals
How Investors Are Reacting To Green Thumb Industries (CNSX:GTII) Strong 2025 Profits and Softer Q1 Outlook
In February 2026, Green Thumb Industries Inc. reported fourth-quarter 2025 sales of US$311.13 million and net income of US$83.2 million, alongside full-year 2025 sales of US$1.18 billion and net income of US$114.15 million, with both basic and diluted earnings per share from continuing operations higher than the prior year.
On the same day, management cautioned that first-quarter 2026 revenues are expected to be sequentially down mid-single digits due to pricing pressure and seasonality,...